Evologic International Limited (SGX:1H2)
Singapore · Delayed Price · Currency is SGD 0.1200
0.00 (0.00%)
At close: May 12, 2026
Evologic International Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.26 | 1.28 | 1.26 | 1.2 | 1.16 | 2.65 | |
Revenue Growth | -1.87% | 1.03% | 5.34% | 3.81% | -56.48% | -30.23% |
Cost of Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 1.25 |
Gross Profit | 1.23 | 1.25 | 1.23 | 1.17 | 1.13 | 1.4 |
Selling, General & Admin | 1.22 | 1.02 | 1.34 | 1.29 | 1.46 | 2.12 |
Other Operating Expenses | 0.23 | 0.23 | 0.12 | 0.1 | 0.11 | 0.11 |
Operating Expenses | 2.08 | 1.88 | 2.11 | 2.01 | 2.17 | 2.22 |
Operating Income | -0.85 | -0.63 | -0.88 | -0.84 | -1.04 | -0.82 |
Interest Expense | -0.11 | -0.17 | -0.28 | -0.19 | -0.24 | -0.28 |
Interest & Investment Income | 0.06 | 0.06 | 0.07 | 0.14 | 0.01 | 0.01 |
Earnings From Equity Investments | - | - | 0.33 | 0.19 | -0.02 | -0.03 |
Currency Exchange Gain (Loss) | -0.14 | -0.14 | 0.01 | -0 | -0 | -0 |
Other Non Operating Income (Expenses) | 0.54 | -0.07 | -0.06 | -0.05 | -0.28 | 0.06 |
EBT Excluding Unusual Items | -0.5 | -0.96 | -0.82 | -0.75 | -1.58 | -1.07 |
Gain (Loss) on Sale of Investments | -0.45 | -0.45 | 0.33 | 0.06 | - | - |
Other Unusual Items | - | - | - | - | 0.02 | 0.06 |
Pretax Income | -0.96 | -1.42 | -0.49 | -0.7 | -1.56 | -1.01 |
Income Tax Expense | 0.06 | 0.06 | 0.05 | 0.07 | 0.1 | 0.16 |
Net Income | -1.02 | -1.47 | -0.53 | -0.77 | -1.65 | -1.17 |
Net Income to Common | -1.02 | -1.47 | -0.53 | -0.77 | -1.65 | -1.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 116 | 116 | 116 | 116 | 69 | 69 |
Shares Outstanding (Diluted) | 116 | 116 | 116 | 116 | 69 | 69 |
Shares Change | -0.40% | - | - | 67.02% | 0.75% | - |
EPS (Basic) | -0.01 | -0.01 | -0.00 | -0.01 | -0.02 | -0.02 |
EPS (Diluted) | -0.01 | -0.01 | -0.00 | -0.01 | -0.02 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.31 | -0.3 | -0.18 | -0.35 | -0.52 | 0.48 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | 0.01 |
Gross Margin | 97.62% | 97.65% | 97.63% | 97.50% | 97.58% | 52.79% |
Operating Margin | -67.54% | -49.53% | -69.75% | -69.97% | -90.13% | -30.93% |
Profit Margin | -80.56% | -115.28% | -42.28% | -63.80% | -143.20% | -44.01% |
Free Cash Flow Margin | -24.44% | -23.82% | -13.86% | -29.19% | -44.85% | 17.90% |
EBITDA | -0.27 | -0.03 | -0.28 | -0.24 | -0.44 | -0.22 |
EBITDA Margin | -21.59% | -2.27% | -22.01% | -19.68% | -37.92% | -8.18% |
D&A For EBITDA | 0.58 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
EBIT | -0.85 | -0.63 | -0.88 | -0.84 | -1.04 | -0.82 |
EBIT Margin | -67.54% | -49.53% | -69.75% | -69.97% | -90.13% | -30.93% |